NOVACYT

NOVACYT

NOVACYT

NOVACYT, founded in 2006, by an experimented team coming from biotech and industrial companies, is active in developing, manufacturing and marketing advanced and innovative solutions for cytology.
Type
B2c
Founded
2006
Raised
$20.2M
Follow us
Alexa global traffic share
Latest funding
€9,700,000
Post-IPO equity - 2017
€7,750,000
Post-IPO equity - 2016
Team Size
2
Employees
Location
Headquarters
€7,750,000 Post-IPO equity
businessweekly

Novacyt raises €7.75m to complete Primerdesign acquisition | Business Weekly | Technology News | Business news | Cambrid...

Strategy Earnings